/
/
/
/
/
ORBAX® Oral Suspension
Canine Antibiotics
Product Description
ORBAX® (Orbifloxacin) Oral Suspension is a broad spectrum antibiotic treatment that is indicated for skin infections and urinary tract infections in dogs.
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| ORBAX® Oral Suspension | 6 x 20 mL | 8713184097552 | 055219 |
Images
Collateral
Important Safety Information
ORBAX® Oral Suspension: Quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. Orbifloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. In animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation, which may lead to convulsive seizures. The use of fluoroquinolones in cats has been reported to adversely affect the retina and should be used with caution in cats. Blindness has also been reported post-approval in cats. In some cases, blindness has been temporary. See Package Insert for full information including side effects, precautions, warnings and contraindications.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global